Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all.
As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.
Company number: 0744643660
VAT: BE0744643660
Company Details
- Employees
- 130
- Address
- Allée Centrale De Jumet 52, Jumet,6040,belgium
- Industry
- Biotechnology
- Website
- exothera.world
- HQ
- Jumet
Exothera Questions
Exothera's website is exothera.world
Exothera's LinkedIn profile is https://be.linkedin.com/company/exothera
Exothera has
130 employees.
View email and phone details for 130
employees at Exothera.
Exothera's industry is
Biotechnology
Exothera's top competitors are
Univercells,
Celyad Oncology,
Ucb,
Novadip Biosciences S.a.,
Cellistic,
Unizima,
Eurogentec,
Quantoom Biosciences,
Bepharbel Manufacturing Sa,
Iteos Therapeutics.
Exothera's categories are Biotechnology
